Protol for infertility

Reading File

Finding Sources

Searching PubMed

"infertility" AND "management" AND "protocol"

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Now I have comprehensive information to compile a complete infertility protocol. Let me synthesize it.

Protocol for Infertility

1. Definition

The WHO defines infertility as "failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse." More than 10% of couples in the United States seek medical assistance for infertility. — Goldman-Cecil Medicine, p. 2560

2. When to Initiate Evaluation

Criterion	Recommendation
Age < 35 years	After 12 months of regular unprotected intercourse
Age ≥ 35 years	After 6 months
Known risk factors (tubal disease, oligomenorrhea, known male factor)	Immediate evaluation

Couples with complaints of infertility merit evaluation regardless of the length of infertility if clinically indicated.

3. Causes of Infertility (Approximate Incidence)

Male Factors (~40%)

Decreased sperm production: varicocele, testicular failure, endocrine disorders, cryptorchidism, stress/toxins
Ductal obstruction: epididymal (post-infection), congenital absence of vas deferens, post-vasectomy
Inability to deliver sperm: ejaculatory disturbances, hypospadias, sexual dysfunction
Abnormal semen: infection, abnormal volume/viscosity
Immunologic: sperm-immobilizing or sperm-agglutinating antibodies

Female Factors

Cause	Incidence
Fallopian tube disease (PID, endometriosis, adhesions)	20–30%
Amenorrhea/anovulation	~15%
Cervical/uterine factors (fibroids, polyps, Asherman syndrome)	~10%
Minor ovulatory disturbances	<5%
Vaginal factors	<5%
Immunologic factors	<5%
Nutritional/metabolic (thyroid, DM)	~5%
Idiopathic/unexplained	<10%

In ~1/3 of couples, more than one cause contributes. Peak female fertility is at age 25; reproductive performance declines after this age in both sexes.

4. Initial Evaluation

History

Both partners should be interviewed together and separately
Menstrual history, previous pregnancies, sexual history, prior STIs, contraceptive use, medications, toxin/substance exposure
Surgical history (especially pelvic/abdominal), systemic illness (thyroid, DM)

Physical Examination

Both partners; include BMI, thyroid, secondary sexual characteristics, pelvic exam

Laboratory/Investigations

Female

Ovulation documentation: basal body temperature chart, serum progesterone 6–8 days before expected menses (mid-luteal), or serum LH surge testing
Hormonal profile: FSH, LH, estradiol (day 2–3 cycle), AMH (ovarian reserve), TSH, prolactin
Genital tract evaluation: hysterosalpingography (HSG) or sonohysterography
Diagnostic laparoscopy with tubal dye instillation — if all previous tests are normal (may reveal endometriosis or tubal disease in 30–50%)

Male

Semen analysis — the cornerstone: volume, concentration, motility, morphology (WHO criteria)
If abnormal: hormonal workup (FSH, LH, testosterone, prolactin), scrotal ultrasound, karyotype, cystic fibrosis mutation testing

5. Treatment by Cause

5a. Male Factor Infertility

Severity	Treatment
Mild–moderate oligospermia	Intrauterine insemination (IUI)
Severe oligospermia / azoospermia	IVF + ICSI (intracytoplasmic sperm injection)
Ductal obstruction	Surgical correction or IVF/ICSI
Donor insemination	Option where male factor uncorrectable

5b. Anovulation / Ovulation Induction

Step 1 — Clomiphene Citrate

50 mg orally daily × 5 days, starting day 3–5 of cycle
If no ovulation: increase by 50 mg increments each cycle → max 200–250 mg/day
Continue highest effective dose for 3–6 months before considering non-responsive
Timed intercourse every other day from days 5–12 post-last dose, or IUI
Document ovulation with mid-luteal progesterone
Equivalent alternative: Letrozole (off-label; slightly lower multiple gestation rate)
hCG trigger (5,000–10,000 IU IM) may be used 7 days after last clomiphene dose

Step 2 — Gonadotropin Therapy (clomiphene failures)

FSH/hMG 75–300 IU/day IM or SC × 5–12 days
Monitor with transvaginal ultrasound + serum estradiol
GnRH antagonist (ganirelix 0.25 mg/day or cetrorelix 0.25 mg/day) to suppress premature LH surge
Trigger with hCG (5,000–10,000 IU) when follicle(s) mature
Withhold hCG if >3 follicles mature (↑ multiple gestation / OHSS risk)
Pregnancy rate ~50–70%; multiple pregnancy rate ~30%

Step 3 — IVF (failed gonadotropins or tubal disease)

5c. Hyperprolactinemia

Cabergoline 0.25 mg twice weekly (preferred) or bromocriptine 2.5 mg/day
Induces ovulation and pregnancy in ~80% of hyperprolactinemic women
Stop drug when pregnancy confirmed

5d. Tubal Factor

Surgical repair (tuboplasty) — considered but success rates often lower than IVF
IVF is generally preferred for significant tubal disease

5e. Endometriosis

Surgical excision of minimal–mild endometriosis → improves monthly fecundity rate
Moderate–severe disease with anatomical distortion → IVF
Medical suppression (GnRH agonists, progestins) treats pain but does not improve fertility while on treatment

5f. Uterine/Cervical Factors

Fibroids/polyps: hysteroscopic resection
Asherman syndrome: hysteroscopic adhesiolysis
Cervical factor: bypass with IUI

5g. Unexplained Infertility

Clomiphene or gonadotropins + IUI (superovulation + IUI)
If 3–6 IUI cycles fail → IVF

6. Assisted Reproductive Technologies (ART)

Technique	Indication
IUI	Mild male factor, cervical factor, unexplained
IVF	Tubal disease, severe male factor, failed ovulation induction, advanced age
ICSI	Severe oligospermia, azoospermia (surgically retrieved sperm), prior IVF fertilization failure
Donor oocytes	Premature ovarian insufficiency, advanced age, poor ovarian reserve
Preimplantation genetic testing (PGT)	Recurrent miscarriage, known genetic disorders, aneuploidy screening

7. Complications to Monitor

Complication	Source	Management
Ovarian Hyperstimulation Syndrome (OHSS)	Gonadotropin/hCG therapy	Withhold hCG if >3 follicles; fluid/electrolyte monitoring; avoid pelvic exams
Multiple gestation	Ovulation induction (up to 30% with gonadotropins)	Limit follicles; consider elective single embryo transfer with IVF
Ectopic pregnancy	↑ risk ×4–40 with infertility treatment	Serial β-hCG + TVUS; treat with methotrexate or surgery
Vasomotor flushes, visual changes	Clomiphene	Dose reduction or discontinuation

8. Special Considerations

Age >35: accelerate evaluation; consider IVF earlier; discuss ovarian reserve (AMH, AFC, Day 3 FSH)
Diminished ovarian reserve (DOR): recent evidence suggests no single intervention is definitively superior; IVF with or without adjuncts remains standard (Conforti et al., Fertil Steril 2025, PMID: 39332623)
Thyroid disease / diabetes: treat underlying condition before ovulation induction
BMI optimization: obesity and underweight both impair ovulation; lifestyle intervention first
Smoking: counsel cessation — dose-dependent adverse effect on fertility and ectopic risk

Sources: Goldman-Cecil Medicine (22nd ed.), p. 2560–2562 | Berek & Novak's Gynecology | Harrison's Principles of Internal Medicine 22E

What role does acupuncture have

Finding Sources

Searching PubMed

"acupuncture" AND "infertility" AND "IVF"

Reading File

Reading Article

Acupuncture in Infertility

The role of acupuncture is promising but not definitively established — the evidence base is growing but inconsistent, and current guidelines do not recommend it as a standalone treatment. Here is a structured summary:

Proposed Mechanisms of Action

Acupuncture is hypothesized to affect fertility through:

Neuroendocrine modulation — influencing hypothalamic-pituitary-ovarian axis signaling
Increased uterine and ovarian blood flow
Cytokine modulation — reducing pro-inflammatory mediators
Stress reduction — lowering cortisol and sympathetic tone, which independently impairs fertility
Protocols are typically designed to promote uterine relaxation and improved endometrial receptivity

— Berek & Novak's Gynecology, p. 1164

Evidence by Clinical Context

1. Anovulation / PCOS

Electroacupuncture in anovulatory women with PCOS induced regular ovulation in >1/3 of women in early studies
Auricular acupuncture studied for infertility secondary to oligomenorrhea and luteal insufficiency — concluded to be a "valuable therapy" in small early trials

2. Acupuncture Around IVF / Embryo Transfer

This is the most-studied area. Results are mixed:

Study	Design	Pregnancy rate: Acupuncture vs. Control
Smith et al. (228 women)	RCT	31% vs. 23% (not statistically significant)
Paulus et al. (225 women)	RCT	33.6% vs. 15.6% clinical; 28.4% vs. 13.8% ongoing
Westergaard et al. (182 women)	RCT	39% vs. 26% clinical; 36% vs. 22% ongoing
RCT (pre/post transfer)	RCT	43% vs. 26%

A meta-analysis of 7 trials (1,366 women) concluded acupuncture around embryo transfer improved pregnancy and live birth rates in IVF
A contradicting meta-analysis of 13 trials (2,500 women) found insufficient evidence to conclude acupuncture improves IVF clinical pregnancy rates

— Berek & Novak's Gynecology, p. 1163–1164

3. Endometrial Receptivity

A 2025 overview of 10 systematic reviews (PMID: 40950975) found:

Combining acupuncture with other treatments (medications, herbal medicine, IVF-ET) may improve pregnancy and ovulation rates
Critically: all 10 included SRs were rated critically low quality by AMSTAR-2; 93% of outcomes were low/very low quality by GRADE
Conclusion: "Definitive conclusions require high-quality RCTs with standardized outcome measures"

4. Poor Ovarian Response (POR)

A 2026 multicenter RCT (140 women, 9 hospitals, PMID: 41837144) found:

No significant difference in oocytes retrieved (primary outcome)
Higher embryo cleavage rate in acupuncture group (100% vs. 87%; p<0.001)
Lower basal FSH post-treatment in acupuncture group
Clinical pregnancy (34% vs. 21%) and live birth (21% vs. 16%) differences were not statistically significant
No serious adverse events

Safety

Acupuncture appears safe in early pregnancy and throughout fertility treatment. No increased risk of congenital anomalies or miscarriage has been demonstrated in the available literature.

Mind-Body Context

Stress is a recognized contributor to reduced fertility. Mind-body therapies (relaxation, CBT, hypnosis, acupuncture) may act partly through stress reduction. Studies of group psychological support and hypnosis alongside IVF have shown pregnancy rates of 53–56% vs. 20–28% in controls — suggesting the neuroendocrine stress pathway is a legitimate target.

Clinical Bottom Line

Recommendation	Strength
Safe to recommend as adjunct; will not harm	Strong
May reduce stress and improve wellbeing	Moderate evidence
May improve IVF pregnancy rates when used around embryo transfer	Weak-to-moderate; inconsistent RCTs
Cannot replace standard ovulation induction or ART	Definitive
Routine recommendation as standalone fertility treatment	Insufficient evidence

The evidence is intriguing but not conclusive. Clinically, acupuncture is reasonable to offer as a complementary adjunct — particularly around embryo transfer and for stress management — with the caveat that it should never delay or replace evidence-based treatment.

Could you make a powerpoint actual downloadable one explaining western then eastern medicibe approach to fertility and how to integrate them together?

Reading File

Running Command

Writing File

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Try again

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

How do i purchase

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.